These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38509230)

  • 1. Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis.
    Fritze S; Brandt GA; Volkmer S; Daub J; Krayem M; Kukovic J; Schwarz E; Braun U; Northoff G; Wolf RC; Kubera KM; Meyer-Lindenberg A; Hirjak D
    Eur Arch Psychiatry Clin Neurosci; 2024 Oct; 274(7):1625-1637. PubMed ID: 38509230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach.
    Fritze S; Brandt GA; Benedyk A; Moldavski A; Volkmer S; Daub J; Krayem M; Kukovic J; Schwarz E; Braun U; Wolf RC; Kubera KM; Northoff G; Meyer-Lindenberg A; Tost H; Hirjak D
    Schizophr Bull; 2024 Apr; ():. PubMed ID: 38665097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving forward: distinct sensorimotor abnormalities predict clinical outcome after 6 months in patients with schizophrenia.
    Sambataro F; Fritze S; Rashidi M; Topor CE; Kubera KM; Wolf RC; Hirjak D
    Eur Neuropsychopharmacol; 2020 Jul; 36():72-82. PubMed ID: 32522386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of childhood/adolescent and adult onset schizophrenia: does the neurocognitive and psychosocial outcome differ?
    Grover S; Sahoo S; Nehra R
    Asian J Psychiatr; 2019 Jun; 43():160-169. PubMed ID: 31176081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study.
    Gupta A; Mahnken JD; Bernal J; Sharma P; Lepping RJ; Montgomery RN; Johnson DK; Parks A; Burns JM; Drew DA; Sarnak MJ; Brooks WM
    Am J Kidney Dis; 2024 Jul; 84(1):28-37.e1. PubMed ID: 38423160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between cognitive functioning and psychopathology in patients with psychiatric disorders: a transdiagnostic network analysis.
    Chavez-Baldini U; Nieman DH; Keestra A; Lok A; Mocking RJT; de Koning P; Krzhizhanovskaya VV; Bockting CLH; van Rooijen G; Smit DJA; Sutterland AL; Verweij KJH; van Wingen G; Wigman JTW; Vulink NC; Denys D
    Psychol Med; 2023 Jan; 53(2):476-485. PubMed ID: 34165065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial.
    Dal Santo F; Fonseca-Pedrero E; García-Portilla MP; González-Blanco L; Sáiz PA; Galderisi S; Giordano GM; Bobes J
    Eur Psychiatry; 2022 Jun; 65(1):e33. PubMed ID: 35686446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder.
    Forno G; Henríquez F; Ceballos ME; Gonzalez M; Schröder J; Toro P
    Neuropsychologia; 2020 Sep; 146():107545. PubMed ID: 32593722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of co-altered brain structure and function underlying neurological soft signs in schizophrenia spectrum disorders.
    Hirjak D; Rashidi M; Fritze S; Bertolino AL; Geiger LS; Zang Z; Kubera KM; Schmitgen MM; Sambataro F; Calhoun VD; Weisbrod M; Tost H; Wolf RC
    Hum Brain Mapp; 2019 Dec; 40(17):5029-5041. PubMed ID: 31403239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the interplay between core and mood symptoms in schizophrenia: A network analysis.
    Wang Y; Xu Y; Wu P; Zhou Y; Zhang H; Li Z; Tang Y
    Schizophr Res; 2024 Jul; 269():28-35. PubMed ID: 38723518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report].
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Pankowski D; Denisiuk M; Linke M; Jarema M; Wichniak A
    Psychiatr Pol; 2014; 48(6):1189-200. PubMed ID: 25717488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Neurological Soft Signs and Cognition in Schizophrenia.
    Nathani YL; Faye A; Kirpekar V; Gawande S; Tadke R; Bhave S; Ingole N; Bandre GR
    Cureus; 2023 Dec; 15(12):e50925. PubMed ID: 38249218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
    Cao X; Chen S; Xu H; Wang Q; Zhang Y; Xie S
    Psychiatry Res; 2022 Jul; 313():114616. PubMed ID: 35576626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological soft signs and neurocognitive deficits in remitted patients with schizophrenia, their first-degree unaffected relatives, and healthy controls.
    Feng Y; Wang Z; Lin G; Qian H; Gao Z; Wang X; Li M; Hu X; Li Y
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):383-391. PubMed ID: 31123823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
    Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
    Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.